巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Medicinova

    MNOV
    2.430
    0.010
    0.41%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Medicinova - 延遲價格・最後更新於 20/05 12:15
    最高位
    2.430
    最低位
    2.350
    開市價
    --
    前收市價
    2.420
    成交量(千)
    1.02
    成交額(百萬)
    0.02
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    119.18
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    5.090 - 2.090
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Medicinova
    證券代碼
    MNOV.US
    所屬板塊
    Biotechnology
    公司業務
    MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of the small molecule therapeutics segments.
    發行量
    49043246
    公司總部
    4275 Executive Square, Suite 300
    公司網址
    https://www.medicinova.com
    公司電郵
    info@medicinova.com
    公司電話
    +1 858 373-1500
    暫無內容

    關於

    Medicinova(MNOV.US)所屬的行業板塊為Biotechnology。
    MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of the small molecule therapeutics segments.
    詳細公司背景可參考: https://www.medicinova.com